Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Interleukin-11 treatment protected against cerebral ischemia/reperfusion injury.

Zhang B, Zhang HX, Shi ST, Bai YL, Zhe X, Zhang SJ, Li YJ.

Biomed Pharmacother. 2019 Jul;115:108816. doi: 10.1016/j.biopha.2019.108816. Epub 2019 May 13.

2.
3.

Optimal timing of staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel disease.

Zhao XD, Zhao GQ, Wang X, Shi ST, Zheng W, Guo RF, Nie SP.

J Geriatr Cardiol. 2018 May;15(5):356-362. doi: 10.11909/j.issn.1671-5411.2018.05.005.

4.

Association Between Uric Acid and Metabolic Syndrome in Elderly Women.

Wang HJ, Shi LZ, Liu CF, Liu SM, Shi ST.

Open Med (Wars). 2018 May 9;13:172-177. doi: 10.1515/med-2018-0027. eCollection 2018.

5.

Acute Abdominal Pain in a Man in His 50s.

Tang Q, Shi ST, Qin T.

JAMA Surg. 2017 Nov 1;152(11):1076-1077. doi: 10.1001/jamasurg.2017.3441. No abstract available.

PMID:
28975277
6.

Triiodo-L-Thyronine Promotes the Maturation of Cardiomyocytes Derived From Rat Bone Marrow Mesenchymal Stem Cells.

Shi ST, Wu XX, Hao W, Wang X, Miao HT, Zhen L, Nie SP.

J Cardiovasc Pharmacol. 2016 May;67(5):388-93. doi: 10.1097/FJC.0000000000000363.

PMID:
26808713
7.

Subclavian steal syndrome decreases neurogenesis in the cerebellar cortex and affects cognitive function in rabbits.

Fu XY, Zhang ZD, Liang K, Shi ST, Wang GQ, Zhang KW, Li K, Li WX, Li TX, Zhai ST.

Exp Ther Med. 2015 Oct;10(4):1455-1459. Epub 2015 Aug 5.

8.

Visible red and infrared light alters gene expression in human marrow stromal fibroblast cells.

Guo J, Wang Q, Wai D, Zhang QZ, Shi SH, Le AD, Shi ST, Yen SL.

Orthod Craniofac Res. 2015 Apr;18 Suppl 1:50-61. doi: 10.1111/ocr.12081.

9.

Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.

Shi ST, Li YF, Guo YQ, Wang ZH.

J Cardiovasc Pharmacol. 2014 Nov;64(5):407-11. doi: 10.1097/FJC.0000000000000133.

PMID:
24979391
10.

Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.

Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, Chan KH, Chan AS, Tsui WY, Ho SL, Chan AK, Man JL, Foglizzo V, Ng MK, Chan AS, Ching YP, Cheng GH, Xie T, Fernandez J, Li VS, Clevers H, Rejto PA, Mao M, Leung SY.

Nat Genet. 2014 Jun;46(6):573-82. doi: 10.1038/ng.2983. Epub 2014 May 11.

PMID:
24816253
11.

Retrograde coronary venous infusion provides targeted cell engraftment into infarcted myocardium.

Wang X, Nie SP, Zhen L, Miao HT, Wu XX, Ren HM, Shi ST.

Int J Cardiol. 2014 Mar 15;172(2):e279-81. doi: 10.1016/j.ijcard.2013.12.202. Epub 2014 Jan 8. No abstract available.

PMID:
24461970
12.

Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871).

Pavlicek A, Lira ME, Lee NV, Ching KA, Ye J, Cao J, Garza SJ, Hook KE, Ozeck M, Shi ST, Yuan J, Zheng X, Rejto PA, Kan JL, Christensen JG.

Mol Cancer Ther. 2013 Dec;12(12):2929-39. doi: 10.1158/1535-7163.MCT-13-0442-T. Epub 2013 Oct 9.

13.

Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.

Li YJ, Wang ZH, Zhang B, Zhe X, Wang MJ, Shi ST, Bai J, Lin T, Guo CJ, Zhang SJ, Kong XL, Zuo X, Zhao H.

J Neuroinflammation. 2013 Jul 5;10:80. doi: 10.1186/1742-2094-10-80.

14.

An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.

Hook KE, Garza SJ, Lira ME, Ching KA, Lee NV, Cao J, Yuan J, Ye J, Ozeck M, Shi ST, Zheng X, Rejto PA, Kan JL, Christensen JG, Pavlicek A.

Mol Cancer Ther. 2012 Mar;11(3):710-9. doi: 10.1158/1535-7163.MCT-11-0184. Epub 2012 Jan 5.

15.

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.

Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan Z, Chan AS, Tsui WY, Lee SP, Ho SL, Chan AK, Cheng GH, Roberts PC, Rejto PA, Gibson NW, Pocalyko DJ, Mao M, Xu J, Leung SY.

Nat Genet. 2011 Oct 30;43(12):1219-23. doi: 10.1038/ng.982.

PMID:
22037554
16.

Skin texture parameters of the dorsal hand in evaluating skin aging in China.

Gao Q, Hu LW, Wang Y, Xu WY, Ouyang NN, Dong GQ, Shi ST, Liu Y.

Skin Res Technol. 2011 Nov;17(4):420-6. doi: 10.1111/j.1600-0846.2011.00513.x. Epub 2011 Feb 22.

PMID:
21338408
17.

HCV 5′ and 3′UTR: When Translation Meets Replication.

Shi ST, Lai MMC.

In: Tan SL, editor. Hepatitis C Viruses: Genomes and Molecular Biology. Norfolk (UK): Horizon Bioscience; 2006. Chapter 2.

18.

[Effects of immune modulation therapy on cardiac function in aged patients with chronic heart failure].

Cao XJ, Li YF, Cao FF, Shi ST, Wang G, Zhang LJ, Liu F.

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Aug;38(8):734-8. Chinese.

PMID:
21055143
19.

Change of expression of renal alpha1-adrenergic receptor and angiotensin II receptor subtypes with aging in rats.

Li YF, Cao XJ, Bai XY, Lin SP, Shi ST.

Aging Clin Exp Res. 2010 Apr;22(2):123-8.

PMID:
20440098
20.

Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges.

Li H, Shi ST.

Future Med Chem. 2010 Jan;2(1):121-41. doi: 10.4155/fmc.09.148. Review.

PMID:
21426049
21.
22.

[Study on water processing conditions of Realgar].

Jiang H, Ding JH, Zhang YH, Shi ST, Gao S, Gong HZ, Sun GF.

Zhong Yao Cai. 2009 Jan;32(1):26-8. Chinese.

PMID:
19445116
23.

Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Shi ST, Herlihy KJ, Graham JP, Nonomiya J, Rahavendran SV, Skor H, Irvine R, Binford S, Tatlock J, Li H, Gonzalez J, Linton A, Patick AK, Lewis C.

Antimicrob Agents Chemother. 2009 Jun;53(6):2544-52. doi: 10.1128/AAC.01599-08. Epub 2009 Mar 23.

24.

Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.

Li H, Tatlock J, Linton A, Gonzalez J, Jewell T, Patel L, Ludlum S, Drowns M, Rahavendran SV, Skor H, Hunter R, Shi ST, Herlihy KJ, Parge H, Hickey M, Yu X, Chau F, Nonomiya J, Lewis C.

J Med Chem. 2009 Mar 12;52(5):1255-8. doi: 10.1021/jm8014537.

PMID:
19209845
25.

Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.

Herlihy KJ, Graham JP, Kumpf R, Patick AK, Duggal R, Shi ST.

Antimicrob Agents Chemother. 2008 Oct;52(10):3523-31. doi: 10.1128/AAC.00533-08. Epub 2008 Aug 11.

26.

In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Shi ST, Herlihy KJ, Graham JP, Fuhrman SA, Doan C, Parge H, Hickey M, Gao J, Yu X, Chau F, Gonzalez J, Li H, Lewis C, Patick AK, Duggal R.

Antimicrob Agents Chemother. 2008 Feb;52(2):675-83. Epub 2007 Dec 10.

27.
28.

[Subcutaneous panniculitis-like T cell lymphoma of pediatrics].

Zheng SF, Wang HP, Li YL, Shi ST, Liu JY.

Zhonghua Er Ke Za Zhi. 2004 Nov;42(11):829. Chinese. No abstract available.

PMID:
15631709
29.

Viral and cellular proteins involved in coronavirus replication.

Shi ST, Lai MM.

Curr Top Microbiol Immunol. 2005;287:95-131. Review.

PMID:
15609510
30.

[A case report of lead encephalopathy].

Wang HP, Zheng SF, Zheng YW, Shi ST, Liu JY.

Zhonghua Er Ke Za Zhi. 2003 Feb;41(2):118. Chinese. No abstract available.

PMID:
14759315
32.
33.
34.
35.

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins.

Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM.

Virology. 2002 Jan 20;292(2):198-210.

36.

Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1.

Shi ST, Huang P, Li HP, Lai MM.

Adv Exp Med Biol. 2001;494:429-36. No abstract available.

PMID:
11774503
37.

Hepatitis C viral RNA: challenges and promises.

Shi ST, Lai MM.

Cell Mol Life Sci. 2001 Aug;58(9):1276-95. Review.

PMID:
11577984
38.

Hepatitis C virus and interferon resistance.

Taylor DR, Shi ST, Lai MM.

Microbes Infect. 2000 Nov;2(14):1743-56. Review.

PMID:
11137047
39.
40.

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein.

Tu H, Gao L, Shi ST, Taylor DR, Yang T, Mircheff AK, Wen Y, Gorbalenya AE, Hwang SB, Lai MM.

Virology. 1999 Oct 10;263(1):30-41.

41.

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.

Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM.

Science. 1999 Jul 2;285(5424):107-10.

42.

Colocalization and membrane association of murine hepatitis virus gene 1 products and De novo-synthesized viral RNA in infected cells.

Shi ST, Schiller JJ, Kanjanahaluethai A, Baker SC, Oh JW, Lai MM.

J Virol. 1999 Jul;73(7):5957-69.

43.
44.
45.

Immunohistoselective sequencing (IHSS) of p53 tumor suppressor gene in human oesophageal precancerous lesions.

Shi ST, Feng B, Yang GY, Wang LD, Yang CS.

Carcinogenesis. 1996 Oct;17(10):2131-6.

PMID:
8895479
46.

Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.

Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL, Yang CS.

Int J Cancer. 1994 Nov 15;59(4):514-9.

PMID:
7960222
47.
48.
50.

[Caries inhibiting effect of ammonium fluoride varnish in vitro].

Shi ST.

Zhonghua Kou Qiang Yi Xue Za Zhi. 1989 Nov;24(6):353-5, 386. Chinese.

PMID:
2517827

Supplemental Content

Support Center